FAST Grant Awarded for Potential Disease-modifying Syn Compound
The Foundation for Angelman Syndrome Therapeutics (FAST) has awarded a research grant to a project testing a new type of therapeutics — a potential disease-modifying compound called Syn — for Angelman syndrome. According to a FAST press release, the grant was awarded to John Marshall, PhD, a…